Matthias Löhn

Title: The Innovative Mind of Matthias Löhn

Introduction

Matthias Löhn, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of medicinal chemistry. With four patents to his name, he has developed groundbreaking compounds that hold the potential to treat various diseases.

Latest Patents

Matthias Löhn's latest innovations include two important patents. The first patent focuses on "Substituted isoquinoline and isoquinolinone derivatives." This invention pertains to 6-substituted isoquinoline and isochinolone derivatives, which are useful for the treatment and/or prevention of diseases associated with Rho-kinase and Rho-kinase mediated phosphorylation of myosin light chain phosphatase, as well as compositions containing such compounds. The second patent, "Cycloalkylamine substituted isoquinolone derivatives," similarly addresses 6-substituted isoquinolone derivatives beneficial for the same medical applications.

Career Highlights

Matthias Löhn has established a noteworthy career at Sanofi, a global healthcare company dedicated to improving health through innovative solutions. His focus on medicinal chemistry has positioned him as a key figure in developing therapeutic agents that target critical biological pathways.

Collaborations

Throughout his career, Matthias has collaborated with talented colleagues, including Oliver Plettenburg and Armin Hofmeister. These partnerships have enabled the pooling of expertise and ideas, resulting in impactful advancements in their field.

Conclusion

Matthias Löhn's inventive spirit and dedication to medicinal chemistry have led to significant advancements in treatment methods for diseases. With his impressive portfolio of patents and collaborative efforts, he continues to play an essential role in the pursuit of innovative solutions in healthcare.